Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.

Source:http://linkedlifedata.com/resource/pubmed/id/19937669

Download in:

View as

General Info

PMID
19937669